Literature DB >> 10535846

Immunomodulation of autoimmune responses with monoclonal antibodies and immunoadhesins: treatment of ocular inflammatory disease in the next millennium.

A D Dick1, J D Isaacs.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10535846      PMCID: PMC1722865          DOI: 10.1136/bjo.83.11.1230

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  83 in total

1.  Adhesion molecule expression in acute and fibrotic sympathetic ophthalmia.

Authors:  M C Kuppner; J Liversidge; S McKillop-Smith; L Lumsden; J V Forrester
Journal:  Curr Eye Res       Date:  1993-10       Impact factor: 2.424

2.  Localization and characterization of major histocompatibility complex class II-positive cells in the posterior segment of the eye: implications for induction of autoimmune uveoretinitis.

Authors:  J V Forrester; P G McMenamin; I Holthouse; L Lumsden; J Liversidge
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-01       Impact factor: 4.799

3.  Cellular autoimmunity to retinal specific antigens in patients with Behçet's disease.

Authors:  J H Yamamoto; M Minami; G Inaba; K Masuda; M Mochizuki
Journal:  Br J Ophthalmol       Date:  1993-09       Impact factor: 4.638

4.  Soluble intercellular adhesion molecule-1 (sICAM-1) as a marker of disease relapse in idiopathic uveoretinitis.

Authors:  A G Zaman; C Edelsten; M R Stanford; E M Graham; B A Ellis; H Direskeneli; D P D'Cruz; G R Hughes; D C Dumonde; G R Wallace
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

5.  Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.

Authors:  M J Elliott; R N Maini; M Feldmann; J R Kalden; C Antoni; J S Smolen; B Leeb; F C Breedveld; J D Macfarlane; H Bijl
Journal:  Lancet       Date:  1994-10-22       Impact factor: 79.321

6.  The efficacy of systemic corticosteroids in sight-threatening retinal vasculitis.

Authors:  L J Howe; M R Stanford; C Edelsten; E M Graham
Journal:  Eye (Lond)       Date:  1994       Impact factor: 3.775

7.  Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis.

Authors:  T Moreau; J Thorpe; D Miller; I Moseley; G Hale; H Waldmann; D Clayton; M Wing; N Scolding; A Compston
Journal:  Lancet       Date:  1994-07-30       Impact factor: 79.321

8.  Effect of LFA-1 and ICAM-1 antibody treatment on murine corneal allograft survival.

Authors:  Y He; J Mellon; R Apte; J Y Niederkorn
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-07       Impact factor: 4.799

9.  Suppression of experimental uveitis with monoclonal antibodies to ICAM-1 and LFA-1.

Authors:  E Uchio; M Kijima; S Tanaka; S Ohno
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-04       Impact factor: 4.799

10.  FK506 treatment of noninfectious uveitis.

Authors:  M Ishioka; S Ohno; S Nakamura; K Isobe; N Watanabe; Y Ishigatsubo; S Tanaka
Journal:  Am J Ophthalmol       Date:  1994-12-15       Impact factor: 5.258

View more
  2 in total

Review 1.  Current concepts and future directions in the pathogenesis and treatment of non-infectious intraocular inflammation.

Authors:  R W J Lee; A D Dick
Journal:  Eye (Lond)       Date:  2011-09-30       Impact factor: 3.775

2.  Ex vivo adenovirus mediated gene transfection of human conjunctival epithelium.

Authors:  J Shen; N Taylor; L Duncan; I Kovesdi; J T Bruder; J V Forrester; A D Dick
Journal:  Br J Ophthalmol       Date:  2001-07       Impact factor: 4.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.